MTHFR Gene Variants: Health Issues and What They Mean

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on methylation & mthfr. Browse all Methylation & MTHFR education

MTHFR is one of the most searched genes in consumer genetics, and for good reason: it sits at the center of methylation, a process your body uses to build DNA, regulate genes, process homocysteine, and support neurotransmitter balance. Common MTHFR variants change how efficiently that machinery runs. Knowing your MTHFR status is not a diagnosis — but it is a useful window into a pathway that touches many systems.

What MTHFR Does

MTHFR stands for methylenetetrahydrofolate reductase, an enzyme that converts folate (vitamin B9) into its active form, 5-methyltetrahydrofolate. That active folate donates methyl groups needed to convert homocysteine into methionine — a step central to the methylation cycle.

When MTHFR works efficiently, homocysteine stays in a healthy range and methylation reactions proceed normally. When enzyme activity is reduced, folate processing slows and homocysteine can accumulate. Because methylation supports DNA synthesis, gene regulation, detoxification, and neurotransmitter production, a bottleneck here can ripple outward.

The Two Common Variants: C677T and A1298C

Two MTHFR variants are studied most often. C677T (rs1801133) is the more functionally significant: one copy of the T allele reduces enzyme activity by roughly a third, and two copies can cut it by more than half, especially when folate intake is low. A1298C (rs1801131) has a milder effect on activity on its own.

Genotype combinations matter. Carrying variants at both positions can compound the effect. Still, having a reduced-activity genotype is common in the general population and does not, by itself, mean anything is wrong — many people with these variants have entirely normal homocysteine levels.

Health Issues Associated With MTHFR Variants

Research has connected reduced MTHFR activity, primarily through elevated homocysteine, to several areas of interest. Elevated homocysteine is a marker studied in cardiovascular health. MTHFR variants have also been examined in the context of pregnancy and neural-tube development, which is part of why folate is emphasized before and during pregnancy. Some studies have explored links to mood and cognition through the methylation-neurotransmitter connection.

These are associations, not certainties. An MTHFR variant shifts a probability within a pathway; it does not determine an outcome, and it does not diagnose any condition. Diet, B-vitamin status, lifestyle, and other genes all shape where you actually land.

What “Management” Really Means

There is no treatment for a genotype — your DNA does not change. What can change is the input the pathway receives. Adequate folate and related B vitamins (B6 and B12) support the methylation cycle, which is why providers often check homocysteine and dietary intake in people with MTHFR variants. Leafy greens, legumes, and folate-rich foods matter here.

Any decision about supplementation — including whether an active folate form is appropriate — should be made with a qualified healthcare provider who can look at your labs and full picture. Self-directed high-dose supplementation is not a substitute for that evaluation.

Pathway-Level Insight and the Bigger Picture

MTHFR is one gene in a larger methylation network that also includes MTR, MTRR, and CBS. Reading it in isolation misses that context. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across peptide-related biological pathways, placing MTHFR alongside the wider methylation and metabolic map. It describes your baseline biology at the pathway level — it does not diagnose, treat, or manage any condition. PlexusDx tells you about your biology; it does not tell you what to put in your body.

Frequently Asked Questions

Is having an MTHFR variant dangerous?

For most people, no. MTHFR variants are common, and many carriers have normal homocysteine and no related issues. The C677T variant (rs1801133) reduces enzyme activity, but diet, B-vitamin status, and other genes shape the outcome. A variant is a tendency within a pathway, not a diagnosis or a guaranteed problem.

What is the difference between C677T and A1298C?

C677T (rs1801133) has the larger effect, reducing MTHFR enzyme activity substantially when two copies are present. A1298C (rs1801131) affects activity more mildly on its own. Carrying variants at both positions can compound the impact. A provider interprets these alongside homocysteine and clinical context, not in isolation.

Should I take methylfolate if I have an MTHFR variant?

That decision belongs with a qualified healthcare provider. Adequate folate and B vitamins support the methylation cycle, but whether supplementation — and which form — is appropriate depends on your labs, diet, and health picture. Genetic results add context; they are not a prescription. Never self-treat based on a genotype alone.

Can genetic testing diagnose a health condition from MTHFR?

No. MTHFR testing describes pathway-level tendencies in folate and methylation biology; it does not diagnose disease. Any condition requires clinical evaluation and lab work interpreted by a provider. The PlexusDx test offers educational insight into your methylation pathway, not a medical diagnosis or treatment plan.

See how your methylation pathway is built beyond a single gene. Take the Precision Peptide Genetic Test for pathway-level genetic insights.

This article is part of the PlexusDx Education Hub. Browse all Methylation & MTHFR education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.